Brief: SymBio Pharmaceuticals says termination of development of patient-controlled pain management drug "SyB P-1501"

SymBio Pharmaceuticals

09/02/2018 08:05

Feb 9 (Reuters) - SymBio Pharmaceuticals Ltd  4582.T   
    
    * Says it terminates the development of "IONSYS" or "SyB 
P-1501" 
in Japan, a drug for patient-controlled, short-term management 
of acute postoperative pain during hospitalization 
 
    Source text in Japanese: https://goo.gl/ikDcFw 
    Further company coverage: 4582.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))